Familial Mediterranean Fever After GnRH Antagonist – Cureus
- A recent case report details the unusual presentation of Familial Mediterranean Fever (FMF) in a patient undergoing treatment with a gonadotropin-releasing hormone (GnRH) antagonist.
- The patient, initially treated with an oral GnRH antagonist, began experiencing recurrent fever, abdominal pain, and a skin rash.
- Initial assessments ruled out common causes of fever and inflammation.
Unexpected Diagnosis: Familial Mediterranean Fever Unveiled After GnRH Antagonist Treatment
Table of Contents
Published November 12,2025
The Complex Case
A recent case report details the unusual presentation of Familial Mediterranean Fever (FMF) in a patient undergoing treatment with a gonadotropin-releasing hormone (GnRH) antagonist. FMF, a periodic fever syndrome, frequently enough manifests in childhood but can remain undiagnosed for years, presenting diagnostic challenges. This case highlights the importance of considering FMF even when symptoms emerge during or after treatment for seemingly unrelated conditions.
GnRH Antagonist and Symptom Emergence
The patient, initially treated with an oral GnRH antagonist, began experiencing recurrent fever, abdominal pain, and a skin rash. These symptoms, while potentially linked to the medication itself, prompted a thorough inquiry that ultimately revealed the underlying FMF diagnosis. GnRH antagonists are commonly used in reproductive medicine to suppress hormone production, and their association with unmasking FMF is a noteworthy clinical observation.
Diagnostic Journey and Confirmation
Initial assessments ruled out common causes of fever and inflammation. However, the persistence of symptoms and a high erythrocyte sedimentation rate (ESR) – a marker of inflammation - led clinicians to suspect an autoinflammatory syndrome. Genetic testing afterward confirmed a mutation associated with FMF, solidifying the diagnosis.This underscores the value of genetic testing in complex cases where clinical presentation is atypical.
Familial Mediterranean Fever: A Deeper Look
Familial Mediterranean Fever is an inherited autoinflammatory disorder most prevalent in people of armenian,Turkish,Arab,and Jewish descent. It’s caused by mutations in the MEFV gene, which regulates the innate immune system. Symptoms typically include recurrent episodes of fever accompanied by inflammation of the serosal membranes (lining of the abdomen,chest,and joints). Untreated FMF can lead to serious complications, including amyloidosis, a buildup of abnormal proteins in organs.
Implications for Clinical Practice
This case serves as a reminder that the initiation of certain medications, like GnRH antagonists, can sometimes unmask underlying genetic conditions. Clinicians shoudl maintain a broad differential diagnosis and consider autoinflammatory syndromes like FMF in patients presenting with unexplained recurrent fever and inflammation, particularly those with relevant ethnic backgrounds. Early diagnosis and treatment with colchicine, the standard therapy for FMF, are crucial to prevent long-term complications.